AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
261.83
-4.14 (-1.56%)
At close: Aug 20, 2026, 4:00 PM EDT
262.12
+0.29 (0.11%)
After-hours: Aug 20, 2026, 7:59 PM EDT

AbbVie Revenue

AbbVie had revenue of $16.99B in the quarter ending June 30, 2026, with 10.16% growth. This brings the company's revenue in the last twelve months to $64.39B, up 10.39% year-over-year. In the year 2025, AbbVie had annual revenue of $61.16B with 8.57% growth.

Revenue (ttm)
$64.39B
Revenue Growth
+10.39%
P/S Ratio
7.19
Revenue / Employee
$1,129,579
Employees
57,000
Market Cap
462.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202561.16B4.83B8.57%
Dec 31, 202456.33B2.02B3.71%
Dec 31, 202354.32B-3.74B-6.44%
Dec 31, 202258.05B1.86B3.30%
Dec 31, 202156.20B10.39B22.69%
Dec 31, 202045.80B12.54B37.69%
Dec 31, 201933.27B513.00M1.57%
Dec 31, 201832.75B4.54B16.08%
Dec 31, 201728.22B2.58B10.06%
Dec 31, 201625.64B2.78B12.16%
Dec 31, 201522.86B2.90B14.52%
Dec 31, 201419.96B1.17B6.23%
Dec 31, 201318.79B410.00M2.23%
Dec 31, 201218.38B936.00M5.37%
Dec 31, 201117.44B1.81B11.55%
Dec 31, 201015.64B1.42B10.02%
Dec 31, 200914.21B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson97.93B
Eli Lilly and Company79.67B
Merck & Co.66.57B
Pfizer63.70B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi55.89B
Novo Nordisk50.34B
Revenue Rankings